A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer
Clinical trial NCT07653893 · RECRUITING
Trial details
- NCT number
- NCT07653893
- Sponsor
- Fudan University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-11
- Primary completion
- 2027-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.